Designing Growth Strategies is in our DNA

Nuclear Medicine Market Size, Share & Industry Analysis, By Type (Diagnostics {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, and Others], and SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, and Others]}, and Therapeutics {Ra-223, Sm-153, Lu-177, I-131, Y-90, and Others}), By Application (Neurology, Cardiology, Oncology, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

Last Updated :July 20, 2026 | Format:PDF | Report ID: 101812

 

Request Sample PDF

man icon
Mail icon
Captcha refresh
Get 30-60 Hours of FREE Customization on this Report
Company Mapping:

Additional company profiling and benchmarking

Competitive Intelligence:

Advanced competitive landscape assessment

Segment Broadening:

Expanded segment-level coverage

Use-Case Analysis:

Tailored application and end-user evaluation

Extended Study Period:

Extended forecast and historical period

Geographic Granularity:

More detailed regional and country-level insights

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 246